Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-24 @ 9:56 PM
NCT ID:
NCT07293832
Eligibility Criteria:
Inclusion Criteria:
* Age between 18 and 80 years
* Patients with electrocardiogram showing ST-segment elevation ≥2 mm in 2 or more contiguous leads for more than 30 minutes
* Estimated time from symptom onset to reperfusion ≤12 hours
* Patients scheduled to undergo primary angioplasty
* Patients who have signed a consent form
Exclusion Criteria:
* Patients receiving chronic medication with beta-adrenergic blockers
* Patients with a previous myocardial infarction
* Persistent systolic blood pressure \<90 mmHg
* Persistent heart rate \<55 beats per minute
* Patients with Killip class III (acute pulmonary edema) or IV (cardiogenic shock) on initial examination
* 12-lead electrocardiogram with PR interval \>200 milliseconds
* 12-lead electrocardiogram showing second- or third-degree atrioventricular block
* Bronchospasm requiring bronchodilator treatment
* Possible pregnancy or postpartum period
* Inability or refusal to sign the consent form
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07293832
Study Brief:
Protocol Section:
NCT07293832